Tickers

1. Composite Trajectory Verdict

Given RTX's capital-intensive aerospace and defense model with long-term contracts, the income statement carries the most weight for assessing operating performance, though cash flow and balance sheet trends provide essential context on conversion and leverage.

Composite Trajectory: Improving

All three financial statements show consistent year-over-year improvement across the 2023–2025 annual period. Revenue grew from $68.9B to $88.6B (+28.5% over two years), operating profit expanded from $3.6B to $9.3B (+161%), and operating margin rose from 5.2% to 10.5%. Operating cash flow dipped in 2024 to $7.2B due to $1.5B in legal and contract termination payments but rebounded to $10.6B in 2025. The balance sheet strengthened with total debt falling from $41.3B to $37.9B, equity rising from $61.9B to $67.1B, and debt-to-capitalization improving from 40% to 36%. Backlog grew from $218B to $268B. No statement shows a deteriorating trend over the full period.

2. Red Flags

• Powder Metal Matter cash outflow persistence: Accrued liabilities for customer compensation remained $0.7B at Dec 31, 2025 after $1.0B utilization in both 2024 and 2025, with an estimated $0.7B further cash impact in 2026 (10-K 2025-12-31, MD&A Cash Flow - Operating Activities; Note 17).
• Recurring "non-recurring" charges: Acquisition accounting adjustments of ~$2.0B/year (2023–2025) and restructuring charges of ~$0.2B/year appear annually despite being framed as discrete (10-K 2025-12-31, Consolidated Statements of Operations; Segment Review Corporate and Eliminations).
• Large contract termination charge and legal settlement in 2024: $0.6B Raytheon Contract Termination charge and $0.9B Resolution of Certain Legal Matters charge in 2024, with combined $1.5B cash paid that year (10-K 2025-12-31, MD&A Results of Operations; Cash Flow - Operating Activities).
• Tariff exposure uncertainty: Management states 2025 results reflect "best estimate of the impact of the tariffs then in effect" but "actual financial impacts...could significantly affect the estimates inherent in our financial statements" (10-K 2025-12-31, MD&A Business Overview Economic Environment).
• China sanctions risk: Escalating sanctions against Raytheon and Collins joint venture noted as potentially disruptive, with uncertain financial impact (10-K 2025-12-31, MD&A Business Overview Geopolitical Matters).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Revenue increased each year: $68.9B (2023) → $80.7B (2024, +17.1%) → $88.6B (2025, +9.7%) (10-K 2025-12-31, Consolidated Statements of Operations). Operating profit rose from $3.6B to $6.5B (+83.6%) to $9.3B (+42.2%), with margins expanding from 5.2% to 8.1% to 10.5% (10-K 2025-12-31, Consolidated Statements of Operations). Net income attributable to common shareowners grew from $3.2B to $4.8B (+49.4%) to $6.7B (+41.0%), and diluted EPS from $2.23 to $3.55 to $4.96 (10-K 2025-12-31, Consolidated Statements of Operations). Organic sales growth was $7.8B in 2024 and $8.9B in 2025 (10-K 2025-12-31, MD&A Results of Operations Net Sales). The 2023 Powder Metal Matter charge ($2.9B pre-tax) and 2024 legal/contract charges create a low base, but the trajectory is unequivocally upward on a GAAP basis.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Operating cash flow declined from $7.9B (2023) to $7.2B (2024) due to $1.5B in combined payments for the Resolution of Certain Legal Matters and Raytheon Contract Termination, then surged to $10.6B (2025) (+47.6% YoY) (10-K 2025-12-31, Consolidated Statements of Cash Flows; MD&A Cash Flow - Operating Activities). Capital expenditures were stable at ~$2.6B annually (10-K 2025-12-31, Consolidated Statements of Cash Flows). Free cash flow (operating cash flow less capex) followed a similar pattern: ~$5.5B (2023) → ~$4.6B (2024) → ~$8.0B (2025). Investing outflows narrowed from -$3.0B to -$1.3B, aided by divestiture proceeds of $1.9B in 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Financing outflows increased due to higher debt repayments ($3.4B in 2025 vs $2.5B in 2024) and dividends ($3.6B vs $3.2B) (10-K 2025-12-31, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Cash and equivalents rose from $5.6B (2024) to $7.4B (2025) after a 2023–2024 dip (10-K 2025-12-31, Consolidated Balance Sheets). Total debt decreased from $41.3B to $37.9B (10-K 2025-12-31, MD&A Liquidity and Financial Condition). Total equity increased from $61.9B to $67.1B (10-K 2025-12-31, Consolidated Balance Sheets). Debt-to-capitalization improved from 40% to 36% (10-K 2025-12-31, MD&A Liquidity and Financial Condition). Current assets grew from $51.1B to $60.3B while current liabilities rose from $51.5B to $58.8B, shifting working capital from -$0.4B to +$1.5B (10-K 2025-12-31, Consolidated Balance Sheets). Total backlog expanded from $218B to $268B, with defense backlog up $14B and commercial backlog up $36B (10-K 2025-12-31, MD&A Segment Review Backlog and Bookings).

6. Data Gaps

• Quarterly GAAP revenue, operating profit, and cash flow for 2026 (only 10-Q headers listed; full 10-Q financial statements not provided in filings)
• 2023 year-end total debt figure (MD&A Liquidity table shows only 2024 and 2025)
• Segment-level organic operating profit for 2023 (MD&A Segment Review shows 2024 and 2025 only)
• Full 2023 balance sheet (Consolidated Balance Sheets show only 2024 and 2025)
• Quarterly backlog and bookings data for 2025–2026 quarters